Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 14, Issue 28, Pages 4576-4579Publisher
W J G PRESS
DOI: 10.3748/wjg.14.4576
Keywords
inflammatory bowel disease; ulcerative colitis; cerebral venous thrombosis; heparin-induced thrombocytopenia; fondaparinux
Categories
Funding
- NCI NIH HHS [R01 CA094143] Funding Source: Medline
Ask authors/readers for more resources
The risk of thromboembolism is increased in inflammatory bowel disease and its symptoms may be overlooked. Furthermore, its treatment can be complex and is not without complications. We describe a case of an adolescent boy who developed a cerebral sinus venous thrombosis during a relapse of his ulcerative colitis and who, while on treatment with heparin, developed heparin-induced thrombocytopenia (HIT). The treatment was then switched to fondaparinux, a synthetic and selective inhibitor of activated factor X. (C) 2008 The WJG Press. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available